Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Sorafenib in Previously Treated Malignant Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Mesothelioma |
| Start Date: | October 1, 2008 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00794859 |
| Study Type: | Interventional |
| Intervention: | Drug: Sorafenib |
| Study Design: | Control: Historical Control|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | King's College London|Bayer |
| Ages: | Adult|Senior |
| Enrollment: | 54 |
| Funded By: | Other|Industry |
| First Received: | November 19, 2008 |
| End Date: | |
| Last Updated: | August 3, 2009 |
| Last Verified: | August 1, 2009 |